Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma GlobeNewswire August 01, 2025 Lymphodepletion Regimen Selection Made in Conjunction with the ALPHA3 Data and Safety Monitoring Board (DSMB) and Steering Committee, and in Consultation with the FDA […]

SecureTech Announces Uplisting to OTCQB Venture Market GlobeNewswire August 01, 2025 Roseville, Minnesota, Aug. 01, 2025 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTCQB: SCTH), a pioneering technology company advancing artificial intelligence, industrial 3D printing and manufacturing technologies, cybersecurity, and digital infrastructure solutions, is pleased to announce that its common stock has been approved for trading

Empro Group Inc. Announces Closing of Remaining Portion of the Underwriter's Over-Allotment Option in Connection with its Upsized Initial Public Offering GlobeNewswire August 01, 2025 Selangor, Malaysia, Aug. 01, 2025 (GLOBE NEWSWIRE) — Empro Group Inc. (the “Company” or “EMPG”), a rising beauty and personal care brand headquartered in Malaysia, today announced that it closed

Bybit, the world's second-largest cryptocurrency exchange by trading volume, is launching a global campaign to accelerate adoption of its newly enhanced Bybit TradFi* platform. Previously known as Gold & FX, the revamped service enables users to trade traditional financial instruments such as gold, forex, stock CFDs, commodities, and indices – all seamlessly integrated within the

(NASDAQ:OCGN), Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial Actively dosing patients in OCU400 Phase 3 liMeliGhT clinical trial and on track for 2026 BLA filing OrthoCellix reverse merger intended to unlock the value of NeoCart/regenerative cell therapies and enable the Company to

Ocugen Provides Business Update with Second Quarter 2025 Financial Results GlobeNewswire August 01, 2025 Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trial Actively dosing patients in OCU400 Phase 3 liMeliGhT clinical trial and on track for 2026 BLA filing OrthoCellix reverse merger intended

Queensland's most significant International Education and Training (IET) and Research and Innovation (R&I) trade mission has taken to the global stage, with 38 of the state's leading institutions and companies visiting World Expo 2025 Osaka, Kansai, Japan in July. Led by Minister for Finance, Trade, Employment and Training, Ros Bates, the delegation was advancing Queensland's

Award-Winning Hotel Re-Emerges with Bold Plans to Expand Its Dining, Wellness, and Nightlife Experiences for In-The-Know Travelers and Locals Alike The 149-room luxury hotel at 8430 W Sunset Blvd has been reborn as The Sun Rose West Hollywood- a proud member of Preferred Hotels & Resorts' L.V.X. Collection. Taking its name from the property's beloved,

Calumet, Inc. (NASDAQ: CLMT) (“Calumet”) announced today that it plans to attend two investor conferences in September 2025. — On Wednesday, September 3rd, Calumet will attend the Barclays 39th Annual CEO Energy-Power Conference and will be holding one-on-one investor meetings at the conference. — On Monday, September 8th, Calumet will attend the H.C. Wainwright 27th

Frontera Energy Corporation (TSX: FEC) (“Frontera”) (the “Company”) and CGX Energy Inc. (TSXV: OYL) (“CGX”) provided today an update on the Corentyne block license. As previously disclosed on May 9, 2025, Frontera and its subsidiaries, Frontera Petroleum International Holding B.V. and Frontera Energy Guyana Holding Ltd. (together, the “Investors”), submitted a notice of intent to